Overview
- Cancer cells alter lipid metabolism not just for energy but to evade the immune system by distorting 'eat me' signals.
- The study identifies sphingolipids, particularly glycosphingolipids, as critical for cancer cell survival and immune evasion.
- Blocking glycosphingolipid synthesis with FDA-approved drugs impaired tumor growth in pancreatic, lung, and colorectal cancer models.
- Depleting glycosphingolipids enhanced the sensitivity of cancer cells to immune responses, making them more vulnerable.
- Future research will explore the potential of dietary and drug interventions targeting lipid metabolism to boost immunotherapy efficacy.